current glp-1 drugs Drugs: 6 Things We've Learned About Their Effects KFF - KFF's latest Health
Description
Battery and data usage also matter
Both tirzepatide and semaglutide showed significant lean mass reduction alongside their stronger overall weight loss results
GLP-1 receptor agonist medications have transformed care for millions of Americans living with obesity and related chronic conditions
Setting clear goals for GLP-1 spend and/or usage
The study also recorded lifestyle factors, such as current smoking status, based on patient self-reports documented in the medical histories within the EMRs dataset
Nausea, diarrhea, decreased appetite, and occasional vomiting are the most common side effects
